Estimaciones de analistas de Wall Street para Eton Pharmaceuticals, Inc. (ETON): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-05 | $0.34 | ||
| 2026-08-13 | $0.35 | $0.19 | +84.4% |
| 2026-05-14 | $0.05 | $0.10 | -50.0% |
| 2026-03-19 | $0.05 | $0.12 | -58.3% |
| 2025-11-06 | $-0.07 | $0.16 | -143.8% |
| 2025-08-07 | $-0.10 | $-0.01 | -900.0% |
| 2025-05-13 | $0.07 | $0.09 | -22.2% |
| 2025-03-18 | $-0.02 | $-0.02 | +0.0% |
Ratios de valoración
| Ratio P/E | 121.18 |
| Precio / Valor contable | 33.44 |
| EV / EBITDA | 86.36 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $959000 | $39000 | $21.8M | $21.3M | $31.6M | $39.0M | $80.0M |
| Coste de Ventas | $13000 | $63000 | $453000 | $286000 | $2.6M | $6.9M | $10.6M | $15.6M | $37.2M |
| Beneficio Bruto | -$13000 | -$63000 | $506000 | -$247000 | $19.2M | $14.3M | $21.1M | $23.4M | $42.7M |
| I+D | $3.9M | $5.6M | $11.6M | $14.1M | $6.2M | $4.0M | $3.3M | $3.3M | $7.8M |
| Generales y Administrativos | $3.2M | $4.7M | $7.6M | $12.8M | $14.5M | $18.6M | $18.9M | $22.8M | $35.8M |
| Gastos Operativos | $7.1M | $10.3M | $19.1M | $26.9M | $20.7M | $22.6M | $22.3M | $26.0M | $42.7M |
| Beneficio Operativo | -$7.2M | -$10.3M | -$18.6M | -$27.1M | -$1.5M | -$8.3M | -$1.2M | -$2.6M | $72000 |
| EBITDA | -$7.1M | -$10.3M | -$18.2M | -$26.5M | -$1.5M | -$7.2M | $212000 | -$657000 | $4.3M |
| Gastos por Intereses | 0 | 0 | 0 | $889000 | $1.0M | $955000 | $1.1M | $2.0M | $4.8M |
| Beneficio Antes de Impuestos | -$7.2M | -$12.7M | -$18.3M | -$28.0M | -$2.0M | -$9.0M | -$689000 | -$3.8M | -$4.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | $247000 | $15000 | $43000 |
| Beneficio Neto | -$7.2M | -$12.7M | -$18.3M | -$28.0M | -$2.0M | -$9.0M | -$936000 | -$3.8M | -$4.6M |
| BPA | $-0.41 | $-1.99 | $-1.02 | $-1.33 | $-0.08 | $-0.36 | $-0.04 | $-0.15 | $-0.17 |
| BPA Diluido | $-0.41 | $-1.99 | $-1.02 | $-1.33 | $-0.08 | $-0.36 | $-0.04 | $-0.15 | $-0.17 |
| Acciones en Circulación (Diluidas) | $17.5M | $6.4M | $17.8M | $21.0M | $25.2M | $25.1M | $25.6M | $25.9M | $26.9M |
Precio
| Precio | $56.35 |
| Capitalización | $1.5B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADCT · BCYC · FULC · LCTX · LXRX · MNPR · NMRA
Explorar sector: Healthcare · Drug Manufacturers - Specialty & Generic
Más secciones de ETON: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones